JCI - Citations to Signal integration: a framework for understanding the efficacy of therapeutics targeting the human EGFR family

Citations to this article

Signal integration: a framework for understanding the efficacy of therapeutics targeting the human EGFR family

H. Michael Shepard, … , Cathleen M. Brdlik, Hans Schreiber

H. Michael Shepard, … , Cathleen M. Brdlik, Hans Schreiber

Published November 3, 2008
Citation Information: J Clin Invest. 2008;118(11):3574-3581. https://doi.org/10.1172/JCI36049.

View: Text | PDF

Total citations by year

Year:	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	Total
Citations:	1	1	2	1	2	5	5	2	1	2	1	4	5	9	5	3	1	50

Citation information

Citations to this article (50)

Title and authors	Publication	Year
EGFR, HER2, and MET gene amplification and protein expression profiles in biliary tract cancer and their prognostic significance. Kim Y, Jee S, Kim H, Paik SS, Choi D, Yoo SH, Shin SJ	The oncologist	2024
Extracellular vesicles derived from Akkermansia muciniphila promote placentation and mitigate preeclampsia in a mouse model Chen Y, Ou Z, Pang M, Tao Z, Zheng X, Huang Z, Wen D, Li Q, Zhou R, Chen P, Situ B, Sheng C, Huang Y, Yue X, Zheng L, Huang L	Journal of Extracellular Vesicles	2023
Consensus for HER2 alterations testing in non-small-cell lung cancer Ren S, Wang J, Ying J, Mitsudomi T, Lee DH, Wang Z, Chu Q, Mack PC, Cheng Y, Duan J, Fan Y, Han B, Hui Z, Liu A, Liu J, Lu Y, Ma Z, Shi M, Shu Y, Song Q, Song X, Song Y, Wang C, Wang X, Wang Z, Xu Y, Yao Y, Zhang L, Zhao M, Zhu B, Zhang J, Zhou C, Hirsch FR	ESMO Open	2022
Chinese expert consensus on the diagnosis and treatment of HER2‐altered non–small cell lung cancer Zhang S, Wang W, Xu C, Zhang Y, Cai X, Wang Q, Song Z, Li Z, Yu J, Zhong W, Wang Z, Liu J, Liu A, Li W, Zhan P, Liu H, Lv T, Miao L, Min L, Lin G, Huang L, Yuan J, Jiang Z, Pu X, Rao C, Lv D, Yu Z, Li X, Tang C, Zhou C, Zhang J, Guo H, Chu Q, Meng R, Liu X, Wu J, Zhou J, Zhu Z, Pan W, Dong X, Pang F, Wang K, Yao C, Lin G, Li S, Yang Z, Luo J, Jia H, Nie X, Wang L, Zhu Y, Hu X, Xie Y, Lin X, Cai J, Xia Y, Feng H, Wang L, Du Y, Yao W, Shi X, Niu X, Yuan D, Yao Y, Kang J, Zhang J, Zhang C, Gao W, Huang J, Zhang Y, Sun P, Wang H, Ye M, Wang D, Wang Z, Wan B, Lv D, Yu G, Shi L, Xia Y, Gao F, Zhang X, Xu T, Zhou W, Wang H, Liu Z, Yang N, Wu L, Wang Q, Wang G, Hong Z, Wang J, Fang M, Fang Y, Zhang Y, Song Y, Ma S, Fang W, Lu Y	Thoracic Cancer	2022
Identifying the hub genes and immune infiltration related to pyroptosis in rheumatoid arthritis. Xie W, Wu Z	Medicine	2021
Role of Heparin-Binding Epidermal Growth Factor-Like Growth Factor in Oxidative Stress-Associated Metabolic Diseases S Kim, V Subramanian, A Abdel-Latif, S Lee	Metabolic Syndrome and Related Disorders	2020
Honokiol Suppression of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Gastric Cancer Cell Biological Activity and Its Mechanism Y Yan, J Xu, G Mao	Medical science monitor : international medical journal of experimental and clinical research	2020
Heparin-binding EGF-like growth factor (HB-EGF) antisense oligonucleotide protected against hyperlipidemia-associated atherosclerosis S Kim, MJ Graham, RG Lee, L Yang, S Kim, V Subramanian, JD Layne, L Cai, RE Temel, D Shih, AJ Lusis, JA Berliner, S Lee	Nutrition, Metabolism, and Cardiovascular Diseases	2019
αvβ3-integrin regulates PD-L1 expression and is involved in cancer immune evasion A Vannini, V Leoni, C Barboni, M Sanapo, A Zaghini, P Malatesta, G Campadelli-Fiume, T Gianni	Proceedings of the National Academy of Sciences	2019
Strategies for Delivery of siRNAs to Ovarian Cancer Cells R Farra, M Maruna, F Perrone, M Grassi, F Benedetti, M Maddaloni, ME Boustani, S Parisi, F Rizzolio, G Forte, F Zanconati, M Cemazar, U Kamensek, B Dapas, G Grassi	Pharmaceutics	2019
The HER2 S310F Mutant Can Form an Active Heterodimer with the EGFR, Which Can Be Inhibited by Cetuximab but Not by Trastuzumab as well as Pertuzumab JW Shin, S Kim, S Ha, B Choi, S Kim, SA Im, TY Yoon, J Chung	Biomolecules	2019
EGFR signaling pathway occupies an important position in cancer‐related downstream signaling pathways of Pyk2 T Shen, Q Guo	Cell Biology International	2019
Simultaneous targeting of EGFR, HER2, and HER4 by afatinib overcomes intrinsic and acquired cetuximab resistance in head and neck squamous cell carcinoma cell lines ID Pauw, F Lardon, JV den Bossche, H Baysal, E Fransen, V Deschoolmeester, P Pauwels, M Peeters, JB Vermorken, A Wouters	Molecular Oncology	2018
Leveraging Genomics for Head and Neck Cancer Treatment JD Kemmer, DE Johnson, JR Grandis	Journal of dental research	2018
Synergistic Targeting HER2 and EGFR with Bivalent Aptamer-siRNA Chimera Efficiently Inhibits HER2-Positive Tumor Growth L Xue, NJ Maihle, X Yu, SC Tang, HY Liu	Molecular Pharmaceutics	2018
Targeting tumor cells with antibodies enhances anti-tumor immunity Z Sun, YX Fu, H Peng	Biophysics Reports	2018
Amplification of Wild-type KRAS Imparts Resistance to Crizotinib in MET Exon 14 Mutant Non–Small Cell Lung Cancer M Bahcall, MM Awad, LM Sholl, FH Wilson, M Xu, S Wang, S Palakurthi, J Choi, EV Ivanova, GC Leonardi, BC Ulrich, CP Paweletz, PT Kirschmeier, M Watanabe, H Baba, M Nishino, RJ Nagy, RB Lanman, M Capelletti, ES Chambers, AJ Redig, PA VanderLaan, DB Costa, Y Imamura, PA Jänne	Clinical cancer research	2018
The EGFR/miR-338-3p/EYA2 axis controls breast tumor growth and lung metastasis Y Liang, X Xu, T Wang, Y Li, W You, J Fu, Y Liu, S Jin, Q Ji, W Zhao, Q Song, L Li, T Hong, J Huang, Z Lyu, Q Ye	Cell Death and Disease	2017
Targeting hepatic heparin-binding EGF-like growth factor (HB-EGF) induces anti-hyperlipidemia leading to reduction of angiotensin II-induced aneurysm development S Kim, L Yang, S Kim, RG Lee, MJ Graham, JA Berliner, AJ Lusis, L Cai, RE Temel, DL Rateri, S Lee, C Schulz	PloS one	2017
Predictive value of EGFR overexpression and gene amplification on icotinib efficacy in patients with advanced esophageal squamous cell carcinoma X Wang, H Niu, Q Fan, P Lu, C Ma, W Liu, Y Liu, W Li, S Hu, Y Ling, L Guo, J Ying, J Huang	Oncotarget	2016
The role of c-Src in the invasion and metastasis of hepatocellular carcinoma cells induced by association of cell surface GRP78 with activated α2M S Zhao, H Li, Q Wang, C Su, G Wang, H Song, L Zhao, Z Luan, R Su	BMC Cancer	2015
Epidermal growth factor receptor protein overexpression and gene amplification are associated with aggressive biological behaviors of esophageal squamous cell carcinoma G Lin, XJ Sun, QB Han, Z Wang, YP Xu, JL Gu, W Wu, G Zhang, JL Hu, WY Sun, WM Mao	Oncology Letters	2015
Bisphosphonates inactivate human EGFRs to exert antitumor actions T Yuen, A Stachnik, J Iqbal, M Sgobba, Y Gupta, P Lu, G Colaianni, Y Ji, LL Zhu, SM Kim, J Li, P Liu, S Izadmehr, J Sangodkar, J Bailey, Y Latif, S Mujtaba, S Epstein, TF Davies, Z Bian, A Zallone, AK Aggarwal, S Haider, MI New, L Sun, G Narla, M Zaidi	Proceedings of the National Academy of Sciences	2014
Huntingtin-interacting protein 1 phosphorylation by receptor tyrosine kinases HM Ames, AA Wang, A Coughran, K Evaul, S Huang, CW Graves, AA Soyombo, TS Ross	Molecular and cellular biology	2013
A novel isoform of the B cell tyrosine kinase BTK protects breast cancer cells from apoptosis: BTK in Breast Cancer C Eifert, X Wang, L Kokabee, A Kourtidis, R Jain, MJ Gerdes, DS Conklin	Genes, Chromosomes and Cancer	2013
Gene amplification of EGFR, HER2, FGFR2 and MET in esophageal squamous cell carcinoma H Kato, T Arao, K Matsumoto, Y Fujita, H Kimura, H Hayashi, K Nishiki, M Iwama, O Shiraishi, A Yasuda, M Shinkai, M Imano, H Imamoto, T Yasuda, K Okuno, H Shiozaki, K Nishio	International journal of oncology	2013
Adaptive Immune Responses and HER2/neu Positive Breast Cancer ED Mortenson, YX Fu	Current Pathobiology Reports	2013
Therapeutic targeting of hyaluronan in the tumor stroma A Kultti, X Li, P Jiang, CB Thompson, GI Frost, HM Shepard	Cancers	2012
CXCL12 and [N33A]CXCL12 in 5637 and HeLa Cells: Regulating HER1 Phosphorylation via Calmodulin/Calcineurin A Rigo, M Gottardi, E Damiani, M Bonifacio, I Ferrarini, P Mauri, F Vinante	PloS one	2012
HER3 intracellular domains play a crucial role in HER3/HER2 dimerization and activation of downstream signaling pathways BK Choi, X Cai, B Yuan, Z Huang, X Fan, H Deng, N Zhang, Z An	Protein & Cell	2012
Epidermal growth factor receptor (EGFR) as a therapeutic target in rheumatoid arthritis FL Yuan, X Li, WG Lu, JM Sun, DL Jiang, RS Xu	Clinical Rheumatology	2012
Dual Targeting of EGFR and HER3 with MEHD7945A Overcomes Acquired Resistance to EGFR Inhibitors and Radiation S Huang, C Li, EA Armstrong, CR Peet, J Saker, LC Amler, MX Sliwkowski, PM Harari	Cancer research	2012
Lung cancer and Toll-like receptors A Pinto, S Morello, R Sorrentino	Cancer Immunology, Immunotherapy	2011
Sarcosine induces increase in HER2/neu expression in androgen-dependent prostate cancer cells M Dahl, P Bouchelouche, G Kramer-Marek, J Capala, J Nordling, K Bouchelouche	Molecular Biology Reports	2011
Human epidermal growth factor receptor bispecific ligand trap RB200: abrogation of collagen-induced arthritis in combination with tumour necrosis factor blockade LL Gompels, NM Malik, L Madden, P Jin, M Feldmann, HM Shepard, EM Paleolog	Arthritis Research & Therapy	2011
Occludin is regulated by epidermal growth factor receptor activation in brain endothelial cells and brains of mice with acute liver failure F Chen, T Hori, N Ohashi, AM Baine, CB Eckman, JH Nguyen	Hepatology	2011
Impact of oncogenic K-RAS on YB-1 phosphorylation induced by ionizing radiation M Toulany, TA Schickfluss, W Eicheler, R Kehlbach, B Schittek, HP Rodemann	Breast Cancer Research	2011
Muscarinic receptor agonists stimulate human colon cancer cell migration and invasion A Belo, K Cheng, A Chahdi, J Shant, G Xie, S Khurana, JP Raufman	AJP Gastrointestinal and Liver Physiology	2011
Epidermal Growth Factor Receptor (EGFR) Crosstalks in Liver Cancer C Berasain, MU Latasa, R Urtasun, S Goñi, M Elizalde, O Garcia-Irigoyen, M Azcona, J Prieto, MA Avila	Cancers	2011
SH3KBP1-binding protein 1 prevents epidermal growth factor receptor degradation by the interruption of c-Cbl-CIN85 complex: SH3KBP1-BINDING PROTEIN 1 AND EGFR DEGRADATION L Feng, JT Wang, H Jin, K Qian, JG Geng	Cell Biochemistry and Function	2011
Anti-HER agents in gastric cancer: from bench to bedside L Fornaro, M Lucchesi, C Caparello, E Vasile, S Caponi, L Ginocchi, G Masi, A Falcone	Nature Reviews Gastroenterology & Hepatology	2011
Lipocalin 2 is essential for chronic kidney disease progression in mice and humans Amandine Viau, Khalil El Karoui, Denise Laouari, Martine Burtin, Clement Nguyen, Kiyoshi Mori, Evangeline Pillebout, Thorsten Berger, Tak W. Mak, Bertrand Knebelmann, Gerard Friedlander, Jonathan Barasch, Fabiola Terzi	Journal of Clinical Investigation	2010
Asbestos, lung cancers, and mesotheliomas: from molecular approaches to targeting tumor survival pathways NH Heintz, YM Janssen-Heininger, BT Mossman	American journal of respiratory cell and molecular biology	2010
Structure of the EGF receptor transactivation circuit integrates multiple signals with cell context EJ Joslin, H Shankaran, LK Opresko, N Bollinger, DA Lauffenburger, HS Wiley	Molecular BioSystems	2010
Macrophages may promote cancer growth via a GM-CSF/HB-EGF paracrine loop that is enhanced by CXCL12 A Rigo, M Gottardi, A Zamò, P Mauri, M Bonifacio, M Krampera, E Damiani, G Pizzolo, F Vinante	Molecular Cancer	2010
Mechanistic insights into acquired drug resistance in epidermal growth factor receptor mutation‐targeted lung cancer therapy Ji H	Cancer Science	2010
Pulmonary surfactant: an immunological perspective ZC Chroneos, Z Sever-Chroneos, VL Shepherd	Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology	2009
Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapy E Martinelli, RD Palma, M Orditura, FD Vita, F Ciardiello	Clinical & Experimental Immunology	2009
Implications for KRAS status and EGFR-targeted therapies in metastatic CRC N Normanno, S Tejpar, F Morgillo, AD Luca, EV Cutsem, F Ciardiello	Nature Reviews Clinical Oncology	2009
MANY CYTOKINES ARE VERY USEFUL THERAPEUTIC TARGETS IN DISEASE Marc Feldmann	Journal of Clinical Investigation	2008

Advertisement